血小板生成素(TPO)活性蛋白
Active Thrombopoietin (TPO)
THPO; MGDF; MKCSF; ML; MPLLG; Myeloproliferative Leukemia Virus Oncogene Ligand; Megakaryocyte Growth And Development Factor; Megakaryocyte Stimulating Factor
- 編號(hào)APA135Mu01
- 物種Mus musculus (Mouse,小鼠) 相同的名稱,不同的物種。
- 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 90%
- 等電點(diǎn)9.6
- 應(yīng)用Cell?culture;?Activity?Assays.
- 下載 英文說(shuō)明書(shū) 中文說(shuō)明書(shū)
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價(jià)格 ¥ 1663 ¥ 4158 ¥ 8316 ¥ 24948 ¥ 62370
- 欲了解實(shí)際交易價(jià)格和更多情況,請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
活性實(shí)驗(yàn)
Thrombopoietin (TPO) is a humoral growth factor that is necessary for megakaryocyte proliferation and maturation, as well as for thrombopoiesis.TPO can promote platelet production, aggregation, ECM adhesion, and activation. It is principally produced in the liver and is bound and internalized by the receptor Tpo R/c-mpl. This protein is the ligand for MLP/C_MPL, the product of myeloproliferative leukemia virus oncogene. Mutations in this gene are the cause of thrombocythemia 1. Besides, GCSF has been identified as an interactor of TPO, thus a functional binding ELISA assay was conducted to detect the interaction of recombinant mouse TPO and recombinant mouse GCSF. Briefly, biotin-linked TPO were diluted serially in PBS, with 0.01% BSA (pH 7.4). Duplicate samples of 100 μl were then transferred to GCSF-coated microtiter wells and incubated for 1h at 37℃. Wells were washed with PBST 3 times and incubation with Streptavidin-HRP for 30 min, then wells were aspirated and washed 5 times. With the addition of substrate solution, wells were incubated 15-25 minutes at 37℃. Finally, add 50 μl stop solution to the wells and read at 450 nm immediately. The binding activity of TPO and GCSF was shown in Figure 1, the EC50?for this effect is 0.68 ug/mL.
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲(chǔ)存
避免反復(fù)凍融。2-8°C不超過(guò)一個(gè)月,-80°C不超過(guò)12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒(méi)有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲(chǔ),損失率低于5%。
贈(zèng)品
增值服務(wù)
相關(guān)產(chǎn)品
編號(hào) | 適用物種:Mus musculus (Mouse,小鼠) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
RPA135Mu01 | 血小板生成素(TPO)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
APA135Mu61 | 血小板生成素(TPO)活性蛋白 | Cell?culture;?Activity?Assays. |
RPA135Mu02 | 血小板生成素(TPO)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
APA135Mu01 | 血小板生成素(TPO)活性蛋白 | Cell?culture;?Activity?Assays. |
PAA135Mu01 | 血小板生成素(TPO)多克隆抗體 | WB; IHC; ICC; IP. |
PAA135Mu02 | 血小板生成素(TPO)多克隆抗體 | WB; IHC; ICC; IP. |
SEA135Mu | 血小板生成素(TPO)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMA135Mu | 血小板生成素(TPO)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
雜志 | 參考文獻(xiàn) |
中國(guó)藥理學(xué)通報(bào) | 黃芪和當(dāng)歸的主要活性成分配伍對(duì)骨髓抑制小鼠造血功能的影響 [] |
Vaccine | The effect of ChAdOx1 nCov-19 vaccine on arterial thrombosis development and platelet aggregation in female rats [Pubmed:35183388] |
Asian Journal of Transfusion Science | A cross-sectional study on thrombopoietin levels in immune thrombocytopenia and its correlation with platelet count, megakaryocytes, and treatment response [] |